CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

Japanese Adverse Drug Event Report database

Open-knowledge reference entry

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 12, 2023
Entity authorityQ117100646 ↗
Source-derived summary

The Japanese Adverse Drug Event Report (JADER) database is a spontaneous reporting system of drug adverse events which is managed by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. It has been available since 2012.

Editorial summary

The public source identifies “Japanese Adverse Drug Event Report database” as open-knowledge reference entry. This brief keeps that definition visible, then builds a research path around Japanese, Adverse and Drug.

Editorial reviewA concise reference frame for defining the subject, testing terminology and identifying the institution closest to the evidence. The current lead gives the account dated anchors—2012—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Japanese, Adverse and Drug providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Japanese Adverse Drug Event Report database”, the useful work is to connect “open-knowledge reference entry” to the records capable of establishing context and consequence.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Aug 12, 2023. The linked authority identifier is Q117100646. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2012.

Critical limits

Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Japanese Adverse Drug Event Report database”, its source revision and the description used here.
  2. Expand the search: follow Japanese Adverse Drug Event Report database primary sources, Japanese Adverse Drug Event Report database archive and Japanese research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Japanese Adverse Drug Event Report database”?
  2. Which institution is responsible for the underlying evidence?
  3. What terminology or title could unlock a more precise catalogue search?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Japanese Adverse Drug Event Report database” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.